That’s been the question floating around ResMed's (ASX:RMD) HQ for the past five years, given its obstructive sleep apnea ...

Stocks in this week’s article are Amphenol APH, GE Aerospace GE, ResMed RMD and Ameriprise Financial AMP. Add These GARP ...

ResMed’s fourth quarter performance drew a positive market reaction, with management attributing the outperformance to strong global demand for its masks and devices, as well as continued growth in ...

ResMed (NYSE:RMD) is seeing growing use of wearable devices for sleep apnea pre screening, widening its reach before patients ever enter a sleep lab. Recent FDA approvals are supporting ResMed's role ...

Air Voel, a fast-growing Canadian provider of sleep therapy and respiratory care equipment, has announced the expansion ...

The Zacks Medical - Products industry is grappling with a challenging operating environment due to the tariffs imposed by the United States on multiple trading partners, including China, Europe and ...

Sleep-breathing device maker ResMed plans to take global a doctor education program aimed at promoting the screening of patients seeking Ozempic-style weight loss drugs for apnea, calling the GLP‑1 ...

Sleep apnea can result in daytime fatigue and irritability. Obstructive Sleep Apnea, defined as having frequent episodes of ...

It was once feared weight-loss drugs would crush demand for sleep apnoea products. ResMed's December quarter has shown very ...

In the second chunky biotech raising so far this year, PYC Therapeutics is seeking $650 million via a placement and rights ...

ResMed dominates the global sleep apnea device market, boasting a 50–60% share and a high-margin razor-razor-blade business ...

Resmed Inc () has held its Q2 earnings call. Read on for the main highlights of the call. Claim 50% Off TipRanks Premium. Unlock hedge fund-level data and powerful investing tools ...